Aristo Bio-Tech and Lifescience Ltd.
•₹ 1080%
2026-08-21
PROS
- Company has delivered good profit growth of 32.2% CAGR over last 5 years
- Strong cash generation - operating cash flow backs reported profits (CFO/PAT 1.29x)
- Working capital cycle has improved - days down from 32 to 23
- Company generates healthy free cash flow
- Attractively priced for its growth - PEG of 0.5
CONS
- Equity base is being diluted - shares outstanding up 36.3%
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | UPL | 568.70 | 23.77 | 48007.91 | 1.05 | -73.00 | 58.52 | 10181.00 | 10.47 | 12.00 | 13.43 |
| 2. | PIIND | 2496.00 | 32.51 | 37868.84 | 0.60 | 244.20 | -38.95 | 1702.30 | -10.43 | 16.00 | 21.69 |
| 3. | SUMICHEM | 553.65 | 47.69 | 27635.20 | 0.23 | 214.51 | 20.45 | 1063.35 | 0.62 | 23.39 | 21.94 |
| 4. | BAYERCROP | 4068.40 | 329.99 | 18284.24 | 3.69 | 321.60 | 15.39 | 1835.00 | -4.16 | 30.08 | 20.03 |
| 5. | SHARDACROP | 771.80 | 11.12 | 6963.22 | 1.94 | 88.02 | -38.36 | 1073.77 | 9.03 | 31.10 | 17.32 |
| 6. | DHANUKA | 995.20 | 14.94 | 4436.43 | 0.20 | 75.50 | 27.94 | 442.02 | 20.01 | 24.44 | 24.83 |
| 7. | RALLIS | 211.90 | 25.10 | 4120.80 | 1.42 | -14.15 | -274.26 | 507.54 | 7.70 | 13.23 | -0.56 |
| 8. | NACLIND | 174.00 | 329.49 | 4075.83 | 0.00 | 20.84 | 59.82 | 383.33 | -14.50 | 6.20 | 10.80 |
| 9. | BHAGCHEM | 290.25 | 136.75 | 3763.65 | 0.05 | 133.29 | 3249.84 | 1950.19 | 1475.55 | 4.55 | 15.65 |
| 10. | GSPCROP | 595.35 | 28.29 | 2769.49 | 0.17 | 263.94 | 1111.46 | 3859.95 | 1153.27 | 20.81 | 11.02 |
| 11. | BHARATRAS | 1279.90 | 14.85 | 2127.33 | 0.04 | 372.30 | 838.73 | 3381.60 | 796.03 | 16.63 | 15.19 |
| 12. | ARISTO | 108.00 | 0.00 | 73.52 | 0.56 | — | — | — | — | 12.96 | — |
Detailed Comparison with:
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
No standalone quarterly results found
We don't have this information yet. Please check back later.
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| 202 | 201 | 167 | 166 | 218 | 245 | 318 | |
| 195 | 197 | 163 | 161 | 209 | 237 | 309 | |
| Operating Profit | 7 | 5 | 5 | 5 | 9 | 9 | 10 |
| OPM % | 3 | 2 | 3 | 3 | 4 | 4 | 3 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Interest | 2 | 3 | 2 | 2 | 3 | 2 | 2 |
| Depreciation | 1 | 1 | 1 | 1 | 2 | 2 | 3 |
| 4 | 1 | 1 | 2 | 5 | 5 | 5 | |
| Tax % | 31 | 28 | 28 | 28 | 25 | 28 | 26 |
| Net Profit | 3 | 1 | 1 | 1 | 4 | 4 | 4 |
| EPS | 6 | 2 | 2 | 3 | 7 | 6 | 6 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 5 | 7 | 8 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 6 | 2 | 2 | 3 | 5 | 6 | 6 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 6 | 2 | 2 | 3 | 5 | 6 | 6 |
Mar 2019
- 202
- 195
- Operating Profit
- 7
- OPM %
- 3
- Other Income
- 0
- Interest
- 2
- Depreciation
- 1
- 4
- Tax %
- 31
- Net Profit
- 3
- EPS
- 6
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 6
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 6
Mar 2020
- 201
- 197
- Operating Profit
- 5
- OPM %
- 2
- Other Income
- 0
- Interest
- 3
- Depreciation
- 1
- 1
- Tax %
- 28
- Net Profit
- 1
- EPS
- 2
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 2
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 2
Mar 2021
- 167
- 163
- Operating Profit
- 5
- OPM %
- 3
- Other Income
- 0
- Interest
- 2
- Depreciation
- 1
- 1
- Tax %
- 28
- Net Profit
- 1
- EPS
- 2
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 2
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 2
Mar 2022
- 166
- 161
- Operating Profit
- 5
- OPM %
- 3
- Other Income
- 0
- Interest
- 2
- Depreciation
- 1
- 2
- Tax %
- 28
- Net Profit
- 1
- EPS
- 3
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 3
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 3
Mar 2023
- 218
- 209
- Operating Profit
- 9
- OPM %
- 4
- Other Income
- 0
- Interest
- 3
- Depreciation
- 2
- 5
- Tax %
- 25
- Net Profit
- 4
- EPS
- 7
- Dividend Payout %
- 5
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 5
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 5
Mar 2024
- 245
- 237
- Operating Profit
- 9
- OPM %
- 4
- Other Income
- 0
- Interest
- 2
- Depreciation
- 2
- 5
- Tax %
- 28
- Net Profit
- 4
- EPS
- 6
- Dividend Payout %
- 7
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 6
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 6
Mar 2025
- 318
- 309
- Operating Profit
- 10
- OPM %
- 3
- Other Income
- 1
- Interest
- 2
- Depreciation
- 3
- 5
- Tax %
- 26
- Net Profit
- 4
- EPS
- 6
- Dividend Payout %
- 8
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 6
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 6
COMPOUNDED SALES GROWTH
- 10 Years:
- —
- 5 Years:
- 10%
- 3 Years:
- 24%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- 32%
- 3 Years:
- 42%
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- 15%
- 1 Year:
- -17%
RETURN ON EQUITY
- 10 Years:
- —
- 5 Years:
- 12%
- 3 Years:
- 13%
- Last Year:
- 11%
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| LIABILITIES | - | - | - | - | - | - | - |
| Equity Capital | 5 | 5 | 5 | 5 | 7 | 7 | 7 |
| 6 | 7 | 8 | 10 | 23 | 27 | 31 | |
| 6 | 8 | 9 | 13 | 10 | 8 | 11 | |
| Trade Payables | 63 | 38 | 38 | 35 | 45 | 69 | 78 |
| 11 | 30 | 20 | 14 | 14 | 16 | 14 | |
| Total Liabilities | 91 | 88 | 81 | 77 | 100 | 127 | 141 |
| ASSETS | - | - | - | - | - | - | - |
| 8 | 8 | 12 | 14 | 16 | 22 | 24 | |
| Capital Work in Progress | 1 | 3 | 0 | 0 | 1 | 0 | 0 |
| 33 | 24 | 32 | 24 | 31 | 40 | 47 | |
| 0 | 0 | 0 | 0 | 0 | 57 | 56 | |
| Cash & Bank | 0 | 1 | 0 | 0 | 2 | 1 | 1 |
| 48 | 52 | 37 | 38 | 50 | 7 | 12 | |
| Total Assets | 91 | 88 | 81 | 77 | 100 | 127 | 141 |
| Total Debt | 14 | 20 | 22 | 25 | 22 | 21 | 22 |
| Net Working Capital | 9 | 12 | 13 | 12 | 23 | 21 | 20 |
| Contingent Liabilities | 2 | 1 | 0 | 1 | 1 | 0 | 0 |
| Book Value per Share | 22.62 | 24.63 | 26.79 | 29.76 | 44.30 | 49.37 | 54.84 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Total Debt | 14 | 20 | 22 | 25 | 22 | 21 | 22 |
| Net Working Capital | 9 | 12 | 13 | 12 | 23 | 21 | 20 |
| Contingent Liabilities | 2 | 1 | 0 | 1 | 1 | 0 | 0 |
| Book Value per Share | 22.62 | 24.63 | 26.79 | 29.76 | 44.30 | 49.37 | 54.84 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Mar 2019
- Equity Capital
- 5
- 6
- 6
- Trade Payables
- 63
- 11
- Total Liabilities
- 91
- 8
- Capital Work in Progress
- 1
- 33
- 0
- Cash & Bank
- 0
- 48
- Total Assets
- 91
- Total Debt
- 14
- Net Working Capital
- 9
- Contingent Liabilities
- 2
- Book Value per Share
- 22.62
- Face Value
- 10.00
- Total Debt
- 14
- Net Working Capital
- 9
- Contingent Liabilities
- 2
- Book Value per Share
- 22.62
- Face Value
- 10.00
Mar 2020
- Equity Capital
- 5
- 7
- 8
- Trade Payables
- 38
- 30
- Total Liabilities
- 88
- 8
- Capital Work in Progress
- 3
- 24
- 0
- Cash & Bank
- 1
- 52
- Total Assets
- 88
- Total Debt
- 20
- Net Working Capital
- 12
- Contingent Liabilities
- 1
- Book Value per Share
- 24.63
- Face Value
- 10.00
- Total Debt
- 20
- Net Working Capital
- 12
- Contingent Liabilities
- 1
- Book Value per Share
- 24.63
- Face Value
- 10.00
Mar 2021
- Equity Capital
- 5
- 8
- 9
- Trade Payables
- 38
- 20
- Total Liabilities
- 81
- 12
- Capital Work in Progress
- 0
- 32
- 0
- Cash & Bank
- 0
- 37
- Total Assets
- 81
- Total Debt
- 22
- Net Working Capital
- 13
- Contingent Liabilities
- 0
- Book Value per Share
- 26.79
- Face Value
- 10.00
- Total Debt
- 22
- Net Working Capital
- 13
- Contingent Liabilities
- 0
- Book Value per Share
- 26.79
- Face Value
- 10.00
Mar 2022
- Equity Capital
- 5
- 10
- 13
- Trade Payables
- 35
- 14
- Total Liabilities
- 77
- 14
- Capital Work in Progress
- 0
- 24
- 0
- Cash & Bank
- 0
- 38
- Total Assets
- 77
- Total Debt
- 25
- Net Working Capital
- 12
- Contingent Liabilities
- 1
- Book Value per Share
- 29.76
- Face Value
- 10.00
- Total Debt
- 25
- Net Working Capital
- 12
- Contingent Liabilities
- 1
- Book Value per Share
- 29.76
- Face Value
- 10.00
Mar 2023
- Equity Capital
- 7
- 23
- 10
- Trade Payables
- 45
- 14
- Total Liabilities
- 100
- 16
- Capital Work in Progress
- 1
- 31
- 0
- Cash & Bank
- 2
- 50
- Total Assets
- 100
- Total Debt
- 22
- Net Working Capital
- 23
- Contingent Liabilities
- 1
- Book Value per Share
- 44.30
- Face Value
- 10.00
- Total Debt
- 22
- Net Working Capital
- 23
- Contingent Liabilities
- 1
- Book Value per Share
- 44.30
- Face Value
- 10.00
Mar 2024
- Equity Capital
- 7
- 27
- 8
- Trade Payables
- 69
- 16
- Total Liabilities
- 127
- 22
- Capital Work in Progress
- 0
- 40
- 57
- Cash & Bank
- 1
- 7
- Total Assets
- 127
- Total Debt
- 21
- Net Working Capital
- 21
- Contingent Liabilities
- 0
- Book Value per Share
- 49.37
- Face Value
- 10.00
- Total Debt
- 21
- Net Working Capital
- 21
- Contingent Liabilities
- 0
- Book Value per Share
- 49.37
- Face Value
- 10.00
Mar 2025
- Equity Capital
- 7
- 31
- 11
- Trade Payables
- 78
- 14
- Total Liabilities
- 141
- 24
- Capital Work in Progress
- 0
- 47
- 56
- Cash & Bank
- 1
- 12
- Total Assets
- 141
- Total Debt
- 22
- Net Working Capital
- 20
- Contingent Liabilities
- 0
- Book Value per Share
- 54.84
- Face Value
- 10.00
- Total Debt
- 22
- Net Working Capital
- 20
- Contingent Liabilities
- 0
- Book Value per Share
- 54.84
- Face Value
- 10.00
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| 8 | 1 | 2 | 7 | -3 | 8 | 10 | |
| Cash from Investing | -2 | -2 | -2 | -3 | -4 | -7 | -5 |
| Cash from Financing | -6 | 1 | -1 | -3 | 8 | -2 | -4 |
| -0 | 0 | -0 | 0 | 1 | -1 | 0 | |
| Free Cash Flow | 8 | -1 | 0 | 4 | -7 | 1 | 5 |
| OCF / Net Profit | 2.88 | 1.40 | 2.12 | 4.73 | -0.78 | 1.95 | 2.47 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 0 | -2 | 4 |
| OCF / Net Profit | 2.88 | 1.40 | 2.12 | 4.73 | -0.78 | 1.95 | 2.47 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 0 | -2 | 4 |
Mar 2019
- 8
- Cash from Investing
- -2
- Cash from Financing
- -6
- -0
- Free Cash Flow
- 8
- OCF / Net Profit
- 2.88
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 2.88
- Cumulative 5-Year FCF
- 0
Mar 2020
- 1
- Cash from Investing
- -2
- Cash from Financing
- 1
- 0
- Free Cash Flow
- -1
- OCF / Net Profit
- 1.40
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.40
- Cumulative 5-Year FCF
- 0
Mar 2021
- 2
- Cash from Investing
- -2
- Cash from Financing
- -1
- -0
- Free Cash Flow
- 0
- OCF / Net Profit
- 2.12
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 2.12
- Cumulative 5-Year FCF
- 0
Mar 2022
- 7
- Cash from Investing
- -3
- Cash from Financing
- -3
- 0
- Free Cash Flow
- 4
- OCF / Net Profit
- 4.73
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 4.73
- Cumulative 5-Year FCF
- 0
Mar 2023
- -3
- Cash from Investing
- -4
- Cash from Financing
- 8
- 1
- Free Cash Flow
- -7
- OCF / Net Profit
- -0.78
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -0.78
- Cumulative 5-Year FCF
- 0
Mar 2024
- 8
- Cash from Investing
- -7
- Cash from Financing
- -2
- -1
- Free Cash Flow
- 1
- OCF / Net Profit
- 1.95
- Cumulative 5-Year FCF
- -2
- OCF / Net Profit
- 1.95
- Cumulative 5-Year FCF
- -2
Mar 2025
- 10
- Cash from Investing
- -5
- Cash from Financing
- -4
- 0
- Free Cash Flow
- 5
- OCF / Net Profit
- 2.47
- Cumulative 5-Year FCF
- 4
- OCF / Net Profit
- 2.47
- Cumulative 5-Year FCF
- 4
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| PER SHARE | - | - | - | - | - | - | - |
| EPS (₹) | 5.66 | 2.02 | 2.15 | 2.87 | 5.23 | 5.72 | 5.97 |
| Book Value (₹) | 22.62 | 24.63 | 26.79 | 29.76 | 44.30 | 49.37 | 54.84 |
| Dividend per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.25 | 0.40 | 0.50 |
| Cash EPS (₹) | 6.68 | 3.06 | 3.65 | 5.07 | 7.49 | 8.03 | 9.79 |
| PROFITABILITY | - | - | - | - | - | - | - |
| Operating Margin % | 2.95% | 1.92% | 2.33% | 3.28% | 4.14% | 3.44% | 2.92% |
| Net Margin % | 1.21% | 0.43% | 0.55% | 0.86% | 1.64% | 1.59% | 1.28% |
| ROE % | 25.03% | 8.54% | 8.38% | 10.15% | 15.82% | 12.22% | 11.46% |
| ROCE % | 24.67% | 13.84% | 11.27% | 11.43% | 16.11% | 13.41% | 12.96% |
| 3.12% | 1.13% | 1.27% | 1.81% | 4.03% | 3.43% | 3.03% | |
| EFFICIENCY | - | - | - | - | - | - | - |
| Debtor Days | 66 | 70 | 75 | 73 | 65 | 76 | 65 |
| Inventory Days | 51 | 44 | 52 | 62 | 46 | 53 | 50 |
| Payable Days | 124 | 98 | 93 | 91 | 75 | 93 | 91 |
| -7 | 17 | 35 | 43 | 36 | 36 | 24 | |
| FINANCIAL HEALTH | - | - | - | - | - | - | - |
| Debt to Equity (x) | 1.28x | 1.60x | 1.66x | 1.71x | 0.75x | 0.62x | 0.59x |
| Interest Coverage (x) | 2.82x | 1.54x | 1.65x | 1.84x | 2.72x | 4.05x | 3.88x |
| 1.12x | 1.18x | 1.23x | 1.23x | 1.39x | 1.26x | 1.21x | |
| GROWTH | - | - | - | - | - | - | - |
| Revenue Growth % | 0.00% | -0.22% | -16.90% | -0.87% | 31.43% | 12.53% | 29.76% |
| Operating Profit Growth % | 0.00% | -34.79% | 1.01% | 19.31% | 65.89% | -3.06% | 13.87% |
| Net Profit Growth % | 0.00% | -64.38% | 6.78% | 33.29% | 148.44% | 9.36% | 4.30% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 9.36% | 4.30% | |
| VALUATION | - | - | - | - | - | - | - |
| P/E (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 10.91x | 19.47x |
| P/B (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 1.27x | 2.12x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.64% | 0.43% |
| 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 7.17x | 10.02x |
Mar 2019
- EPS (₹)
- 5.66
- Book Value (₹)
- 22.62
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 6.68
- Operating Margin %
- 2.95%
- Net Margin %
- 1.21%
- ROE %
- 25.03%
- ROCE %
- 24.67%
- 3.12%
- Debtor Days
- 66
- Inventory Days
- 51
- Payable Days
- 124
- -7
- Debt to Equity (x)
- 1.28x
- Interest Coverage (x)
- 2.82x
- 1.12x
- Revenue Growth %
- 0.00%
- Operating Profit Growth %
- 0.00%
- Net Profit Growth %
- 0.00%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2020
- EPS (₹)
- 2.02
- Book Value (₹)
- 24.63
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 3.06
- Operating Margin %
- 1.92%
- Net Margin %
- 0.43%
- ROE %
- 8.54%
- ROCE %
- 13.84%
- 1.13%
- Debtor Days
- 70
- Inventory Days
- 44
- Payable Days
- 98
- 17
- Debt to Equity (x)
- 1.60x
- Interest Coverage (x)
- 1.54x
- 1.18x
- Revenue Growth %
- -0.22%
- Operating Profit Growth %
- -34.79%
- Net Profit Growth %
- -64.38%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2021
- EPS (₹)
- 2.15
- Book Value (₹)
- 26.79
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 3.65
- Operating Margin %
- 2.33%
- Net Margin %
- 0.55%
- ROE %
- 8.38%
- ROCE %
- 11.27%
- 1.27%
- Debtor Days
- 75
- Inventory Days
- 52
- Payable Days
- 93
- 35
- Debt to Equity (x)
- 1.66x
- Interest Coverage (x)
- 1.65x
- 1.23x
- Revenue Growth %
- -16.90%
- Operating Profit Growth %
- 1.01%
- Net Profit Growth %
- 6.78%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2022
- EPS (₹)
- 2.87
- Book Value (₹)
- 29.76
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 5.07
- Operating Margin %
- 3.28%
- Net Margin %
- 0.86%
- ROE %
- 10.15%
- ROCE %
- 11.43%
- 1.81%
- Debtor Days
- 73
- Inventory Days
- 62
- Payable Days
- 91
- 43
- Debt to Equity (x)
- 1.71x
- Interest Coverage (x)
- 1.84x
- 1.23x
- Revenue Growth %
- -0.87%
- Operating Profit Growth %
- 19.31%
- Net Profit Growth %
- 33.29%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2023
- EPS (₹)
- 5.23
- Book Value (₹)
- 44.30
- Dividend per Share (₹)
- 0.25
- Cash EPS (₹)
- 7.49
- Operating Margin %
- 4.14%
- Net Margin %
- 1.64%
- ROE %
- 15.82%
- ROCE %
- 16.11%
- 4.03%
- Debtor Days
- 65
- Inventory Days
- 46
- Payable Days
- 75
- 36
- Debt to Equity (x)
- 0.75x
- Interest Coverage (x)
- 2.72x
- 1.39x
- Revenue Growth %
- 31.43%
- Operating Profit Growth %
- 65.89%
- Net Profit Growth %
- 148.44%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2024
- EPS (₹)
- 5.72
- Book Value (₹)
- 49.37
- Dividend per Share (₹)
- 0.40
- Cash EPS (₹)
- 8.03
- Operating Margin %
- 3.44%
- Net Margin %
- 1.59%
- ROE %
- 12.22%
- ROCE %
- 13.41%
- 3.43%
- Debtor Days
- 76
- Inventory Days
- 53
- Payable Days
- 93
- 36
- Debt to Equity (x)
- 0.62x
- Interest Coverage (x)
- 4.05x
- 1.26x
- Revenue Growth %
- 12.53%
- Operating Profit Growth %
- -3.06%
- Net Profit Growth %
- 9.36%
- 9.36%
- P/E (x)
- 10.91x
- P/B (x)
- 1.27x
- Dividend Yield %
- 0.64%
- 7.17x
Mar 2025
- EPS (₹)
- 5.97
- Book Value (₹)
- 54.84
- Dividend per Share (₹)
- 0.50
- Cash EPS (₹)
- 9.79
- Operating Margin %
- 2.92%
- Net Margin %
- 1.28%
- ROE %
- 11.46%
- ROCE %
- 12.96%
- 3.03%
- Debtor Days
- 65
- Inventory Days
- 50
- Payable Days
- 91
- 24
- Debt to Equity (x)
- 0.59x
- Interest Coverage (x)
- 3.88x
- 1.21x
- Revenue Growth %
- 29.76%
- Operating Profit Growth %
- 13.87%
- Net Profit Growth %
- 4.30%
- 4.30%
- P/E (x)
- 19.47x
- P/B (x)
- 2.12x
- Dividend Yield %
- 0.43%
- 10.02x
Documents
Announcements
Nothing filed yet.
Annual Reports
Credit Ratings
Nothing filed yet.
Concalls
Nothing filed yet.

